Live Breaking News & Updates on Sirtex pty ltd

Stay informed with the latest breaking news from Sirtex pty ltd on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Sirtex pty ltd and stay connected to the pulse of your community

Sirtex Medical secures positive approval of SIR-Spheres Y-90 resin microspheres for HCC treatment in Brazil

Sirtex Medical secures positive approval of SIR-Spheres Y-90 resin microspheres for HCC treatment in Brazil
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Germany , Australia , Canada , Argentina , Switzerland , Turkey , Brazil , Brazilian , Joaquim-maur , Kevinr-smith , Brazilian-health-regulatory-agency , Brazilian-society-of-interventional-radiology

Sirtex Medical secures positive approval of SIR-Spheres® Y-90 resin microspheres for HCC treatment in Brazil

/PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced that the Brazilian National Agency of...

Germany , Australia , Canada , Argentina , Switzerland , Turkey , Brazil , Brazilian , Joaquim-maur , Kevinr-smith , Brazilian-health-regulatory-agency , Brazilian-society-of-interventional-radiology

Sirtex Medical secures positive approval of SIR-Spheres® Y-90 resin microspheres for HCC treatment in Brazil

Sirtex Medical secures positive approval of SIR-Spheres® Y-90 resin microspheres for HCC treatment in Brazil
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

Germany , Australia , Canada , Argentina , Switzerland , Turkey , Brazil , Brazilian , Joaquim-maur , Kevinr-smith , Brazilian-health-regulatory-agency , Brazilian-society-of-interventional-radiology

Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres® Y-90 resin microspheres in China from the National Medical Products Administration

/PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today with its shareholder, Grand...

China , Australia , Hainan , Chinese , Tang-weikun , Kevinr-smith , Board-at-grand-pharmaceutical-group , National-medical-products-administration , Sirtex-pty-ltd , Grand-pharmaceutical-group-limited , Chief-executive-officer , Sirtex-china

Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres Y-90 resin microspheres in China from the National Medical Products Administration

SIR-Spheres Y-90 resin microspheres are the first therapeutic radiopharmaceutical approved by the NMPA in 2022 WOBURN, Mass., Feb. 9, 2022 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading

China , Australia , Hainan , Chinese , Tang-weikun , Kevinr-smith , Board-at-grand-pharmaceutical-group , National-medical-products-administration , Sirtex-pty-ltd , Grand-pharmaceutical-group-limited , Chief-executive-officer , Sirtex-china

Sirtex Medical and China Grand Pharmaceutical announce successful first administration of SIR-Spheres® Y-90 resin microspheres in China

Press release content from PR Newswire. The AP news staff was not involved in its creation.

China , Australia , Hainan-province , Hainan , Chinese , Jiahong-dong , Kevinr-smith , Healthcare-holdings , National-medical-products-administration , Sirtex-pty-ltd , Academician-of-chinese-academy-engineering , China-grand-pharmaceutical

MIM Software Inc. Receives CE Mark Approval for MAA SPECT/CT Dosimetry

CLEVELAND, Aug. 5, 2021 /PRNewswire/ -- MIM Software Inc., a leading global provider of medical imaging software, announced today it has received CE Mark approval for MAA voxel-based SPECT/CT

Beijing , China , Chengdu , Sichuan , Australia , United-states , Brussels , Bruxelles-capitale , Belgium , Aaron-nelson , Kostenloser-wertpapierhandel , Nick-sewell

DOORwaY-90 study for SIR-Spheres® therapy as first-line treatment for hepatocellular carcinoma enrolls first patient

Press release content from PR Newswire. The AP news staff was not involved in its creation.
DOORwaY-90 study for SIR-Spheres® therapy as first-line treatment for hepatocellular carcinoma enrolls first patient
May 10, 2021 GMT
Sirtex DOORwaY-90 Study Logo
First prospective multicenter U.S.-based trial for indication expansion of SIR-Spheres® Y-90 resin microspheres taking place in 15 sites across the U.S.
WOBURN, Mass., May 10, 2021 /PRNewswire/ -- Sirtex Medical (“Sirtex”), a leading manufacturer of targeted liver cancer therapies, announced that the first patient has been enrolled in DOORwaY-90, a study evaluating the safety and efficacy of selective internal radiation therapy (SIRT) using SIR-Spheres® Y-90 resin microspheres in patients with unresectable hepatocellular carcinoma (HCC).

Australia , Switzerland , Argentina , Washington , United-states , Turkey , Barcelona , Comunidad-autonoma-de-cataluna , Spain , Brazil , Cheenu-kappadath , Armeen-mahvash

Sirtex Medical and BlackSwan Vascular, Inc. announce first patient enrolled in pivotal LAVA Study

Share this article
Share this article
WOBURN, Mass., April 19, 2021 /PRNewswire/ -- Sirtex Medical (Sirtex), a leading manufacturer of targeted liver cancer therapies, and BlackSwan Vascular, Inc. (BlackSwan), a Bay Area-based private company developing groundbreaking therapies in endovascular embolization, announced that the first patient has been enrolled in the LAVA Study to evaluate the safety and effectiveness of the BlackSwan Lava™ liquid embolic system (LES) for the embolic treatment of arterial hemorrhage in the peripheral vasculature.
The LAVA Study, which stands for
Liquid Embolization of
Arterial Hemorrhages in Peripheral
Vasculature, is a prospective, multicenter single-arm study of 113 subjects at 20 investigational sites in the U.S. The first subject has been enrolled at the University of North Carolina School of Medicine in Chapel Hill, North Carolina, where a clinical team successfully treated a patient with a bleeding hypervascular tumor in the liver using the Lava™ LES.

Australia , California , United-states , Rush-university-medical-center , Illinois , North-carolina , University-of-north-carolina , Chapel-hill , Chicago , Sanjay-shrivastava , Bulent-arslan , Kevin-smith

Sirtex Medical receives positive recommendation from National Institute for Health and Care Excellence (NICE) for selective internal radiation therapy (SIRT) using SIR-Spheres

Sirtex Medical receives positive recommendation from National Institute for Health and Care Excellence (NICE) for selective internal radiation therapy (SIRT) using SIR-Spheres
WOBURN, Mass., Feb. 26, 2021 /PRNewswire/ --
Sirtex Medical US Holdings, Inc. ("Sirtex"), a leading manufacturer of targeted cancer therapies, received positive guidance from the National Institute for Health and Care Excellence (NICE) regarding the use of selection internal radiation therapy (SIRT) with SIR-Spheres
Y-90 microspheres for the treatment of adults with unresectable advanced hepatocellular carcinoma (HCC).
NICE recommends the use of SIRT using SIR-Spheres in England and Wales as a fully funded and reimbursed option for adult patients with HCC, on the conditions that it is used for people with Child-Pugh grade A liver impairment when conventional transarterial therapies are inappropriate, and that the company provides SIR-Spheres according to the commercial arrangement.

China , Australia , United-kingdom , British , Paul-ross , Damian-mullan , Kevinr-smith , National-institute-for-health , King-college-hospital , British-liver , Sirtex-pty-ltd , Sirtex-medical-us-holdings-inc